Inhibition of propionibacterium acnes by bacteriocin-like inhibitory substances (BLIS) produced by Streptococcus salivarius.

Whitney P. Bowe, Jennifer C. Filip, Joseph M. DiRienzo, Alla Volgina, David J. Margolis

Research output: Contribution to journalArticlepeer-review

61 Scopus citations

Abstract

We report the in vitro inhibition of Propionibacterium acnes (P. acnes) by a bacteriocin-like inhibitory substance (BLIS-like substance) produced by Streptococcus salivarius (S. salivarius). Bacteriocins are proteinaceous substances produced by bacteria that are capable of inhibiting the growth of similar bacterial strains. Unlike classical antibiotics, they have a relatively narrow spectrum of killing activity, resulting in a reduction in the intensity of selection for resistance. These findings suggest that BLIS may potentially be used for its anti-P. acnes activity in the treatment of acne.

Original languageEnglish
Pages (from-to)868-870
Number of pages3
JournalJournal of Drugs in Dermatology
Volume5
Issue number9
StatePublished - Oct 2006
Externally publishedYes

Fingerprint

Dive into the research topics of 'Inhibition of propionibacterium acnes by bacteriocin-like inhibitory substances (BLIS) produced by Streptococcus salivarius.'. Together they form a unique fingerprint.

Cite this